A Phase 2 Study of WEE1 Inhibition and AZD1775 Alone or Combined With Cytarabine in Patients With Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myelofibrosis
Status: Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 28 May 2019
Price : $35 *
At a glance
- Drugs Adavosertib (Primary) ; Cytarabine (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Myelofibrosis
- Focus Therapeutic Use
- 01 Mar 2019 Planned initiation date changed from 1 Feb 2019 to 1 Apr 2019.
- 17 Dec 2018 Planned initiation date changed from 1 Nov 2018 to 1 Feb 2019.
- 01 Nov 2018 New trial record